Infectivity Detection Assay
Infectivity Detection Assay - Related Videos
03:25
A Lactate Dehydrogenase Release Assay to Detect Cryptococcus neoformans Infection in Macrophages
0 Views •
2025
In this video, we demonstrate a cytotoxicity assay to assess Cryptococcus neoformans, a pathogenic fungus, infection in macrophages. The cytotoxicity is determined by the release of cytoplasmic lactate dehydrogenase enzyme due to macrophage lysis caused by Cryptococcus neoformans infection.
07:59
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
0 Views •
Cited by 3 •
2016
This manuscript describes the use of a bioluminescent strain of African trypanosomes to enable the tracking of late stage infection and demonstrates how in vivo live imaging can be used to visualize infections within the central nervous system in real-time.
06:57
Loop-mediated Isothermal Amplification (LAMP) Assays for the Species-specific Detection of Eimeria that Infect Chickens
0 Views •
Cited by 10 •
2015
Diagnosis of Eimeria infection in chickens remains demanding. Parasite morphology- and host pathology-led approaches are commonly inconclusive, while molecular approaches based on PCR have proven demanding in cost and expertise. The aim of this protocol is to establish loop-mediated isothermal amplification (LAMP) as a straightforward molecular diagnostic for eimerian infection.
02:53
Immunofluorescence Assay to Detect Hepatitis C Virus Replication Complexes in Infected Cells
0 Views •
2026
Source: Ren, S., et al. A Protocol for Analyzing Hepatitis C Virus Replication. J. Vis. Exp. (2014).This video demonstrates an immunofluorescence-based method to detect Hepatitis C virus replication in infected hepatoma cells. The protocol involves cell fixation, antibody staining for viral protein and double-stranded RNA, and visualization using fluorophore-tagged secondary antibodies. Dual signal detection under a fluorescence microscope confirms active viral replication within the host cells.
02:01
Assessing Pseudovirus Infection Using Luciferase Reporter Assay
0 Views •
2026
Source: Chang, X., et al. Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity. J. Vis. Exp. (2021).This video demonstrates a luciferase-based assay to quantify pseudovirus infection in epithelial cells. The pseudovirus encodes the luciferase gene, which is expressed in infected cells. After washing, and cells are incubated with lysis buffer at an ultra-low temperature, and then thawed to induce lysis.
FAQs
Because it measures function rather than simple presence, an infectivity detection assay can separate infectious particles from noninfectious material in the same sample. A detection test may indicate that pathogen-derived material is present, whereas this assay requires evidence that susceptible cultured cells undergo an infection-associated outcome. That distinction is important when estimating biological activity or interpreting treatment effects.
Serial dilution links the observed infection signal to an estimate of infectious units. Diluting the sample across a range reduces the number of infectious events presented to the cultured cells, making the response suitable for quantification. Comparing outcomes across dilutions helps investigators estimate infectious activity rather than relying on a single, potentially saturated measurement.
These readouts provide different observable endpoints for the same functional question: whether infection has occurred in the cultured cells. Cytopathic effects show infection-associated cellular changes, plaques provide countable infection-associated features, and reporter signals provide a measurable indication linked to infection. The selected endpoint determines how infection is recognized and quantified in a given experiment.
Researchers compare infection-related outcomes when the infectious sample is evaluated with and without the antibody condition. A reduction in cytopathic effects, plaques, or reporter signal indicates that the antibodies interfere with productive infection under the assay conditions. This functional measurement helps characterize neutralizing antibodies and connects immune activity with inhibition of pathogen activity.
Investigators place the sample onto susceptible cultured cells under controlled conditions. They may prepare serial dilutions when infectious activity must be estimated, then monitor an infection-associated endpoint such as cytopathic effects, plaque formation, or a reporter signal. The resulting pattern is quantified to compare infectious activity among samples, treatments, or experimental conditions.
It is especially useful when the research question concerns biological activity rather than whether pathogen material remains detectable. Applications include evaluating antiviral treatments, assessing vaccines, measuring neutralizing antibody activity, and distinguishing infectious from noninfectious particles. These uses make the assay relevant to treatment development and to interpreting changes in pathogen activity.
Results can inform risk assessment by indicating whether a sample contains material capable of initiating productive infection under the tested conditions. In immunology and infection research, the measurements also support host-pathogen studies by connecting pathogen activity with cellular infection outcomes. They provide evidence for comparing vaccines, antiviral treatments, or antibody responses.